When Chris Naoum first met with Dr. Kathryn Mileham in 2016, he had stage IV lung cancer that had spread to his brain and lymph nodes. After undergoing radiation, surgery and chemotherapy, an immunotherapy approved in 2017 offered him a new treatment option – and new hope. The outcome exceeded expectations. Today, four years after Chris began immunotherapy, his scans continue to show no evidence of cancer.